Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Novo Nordisk
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
fletikumab
(NNC109-0012) / Novo Nordisk
NN9828
/ Almirall
NNC 0151-0000-0000
/ Novo Nordisk
